AwardedSpainGoods€224,059,795
Suministro de medicamentos de uso humano que contiene los principios activos siguientes: alpelisib, asciminib, basiliximab, brolucizumab, canakinumab, capmatinib, ceritinib, dabrafenib, midostaurina, ofatumumba, ribociclib, ruxolitinib, secukinumab, siponimod y trametinib, con destino a los centros del ámbito de la sanidad pública valenciana
- Published
- Published 12 March 2025
Overview
uministro de medicamentos de uso humano que contiene los principios activos siguientes: alpelisib, asciminib, basiliximab, brolucizumab, canakinumab, capmatinib, ceritinib, dabrafenib, midostaurina, ofatumumba, ribociclib, ruxolitinib, secukinumab, siponimod y trametinib, con destino a los centros del ámbito de la sanidad pública valenciana
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €224,059,795
- Procedure
- Direct
- Published
- 12 March 2025
Antineoplastic agentsImmunosuppressive agentsOphthalmologicals
Award outcome
- Awarded value
- €0
- Award date
- 6 March 2026
- NOVARTIS FARMACEUTICA, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
7 May 2026
Contract Award Notice
10 December 2025
Contract Notice
12 March 2025
Contracting authority
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Procuring entityValencia, Spain
ID_PLATAFORMA: 20897030133463
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.